Perspectives on medicinal properties of benzoquinone compounds

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 5, 2010, Pages 436-454

  Dandawate, P R ^a   Vyas, A C ^b   Padhye, S B ^a   Singh, M W ^c   Baruah, J B ^c  

^a DR DY PATIL UNIVERSITY   (India)

^b UNIVERSITY OF PUNE   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

Author keywords

Anti inflammatory; Anticancer; Antioxidant; Benzoquinone; Benzoquinone analogs; Quinone

Indexed keywords

2,3,5 TRIMETHYL 6 (3 PYRIDYLMETHYL) 1,4 BENZOQUINONE; ALVESPIMYCIN; ANTHRACENE; BENZOQUINONE DERIVATIVE; DAUNORUBICIN; DIAZIQUONE; DOXORUBICIN; DUROQUINONE; EMBELIN; ETHYLENEDIAMINE; GELDANAMYCIN; HERBIMYCIN A; HYDROQUINONE; IDEBENONE; MITOMYCIN; MITOXANTRONE; NALOXONE; NICOTINIC ACID; PLASTOQUINONE; RIBOFLAVIN; TAMOXIFEN; TANESPIMYCIN; THYMOQUINONE; UBIDECARENONE; UBIQUINONE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT;

ALKYLATION; ANALGESIA; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOENERGY; CYTOKINE PRODUCTION; ELECTROCHEMICAL ANALYSIS; ELECTRON TRANSPORT; GENETIC TRANSCRIPTION; IC50; LIPID PEROXIDATION; MEDICINAL PLANT; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NONHUMAN; OXIDATION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PROTEIN DEGRADATION; WOUND HEALING; CHEMISTRY; REVIEW; SYNTHESIS;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BENZOQUINONES;

EID: 77955916188     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955710791330909     Document Type: Article

References (187)

1. Pink, J.J.; Planchon, S.M.; Tagliarino, C.; Varnes, M.E.; Siegel, D.; Boothman, D.A. NAD(P)H: Quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity. J. Biol. Chem., 2000, 275, 5416-5424.
2. Ross, D.; Kepa, J.K.; Winski, S.L.; Beall, H.D.; Anwar, A.; Siegel, D. NAD(P)H: quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem. Biol. Interact., 2000, 129, 77-97.
3. Arntzen, C.J.; Pakrasi, H.B. Photosystem II reaction center: Polypeptide subunits and functional cofactors. In: Encyclopedia of Plant Physiology. New series, Staehelin; L.Al; Arntzen, C.J.; Eds.; Springer-Verlag:Berlin; 1986, Vol 19, pp. 457-467.
4. Lindsey, R.H.; Jr, Bromberg, K.D.; Felix, C.A.; Osheroff, N. 1,4-Benzoquinone is a topoisomerase II poison. Biochemistry, 2004, 43, 7563-7574.
5. Lee, C.S. Excision repair of 2, 5-diaziridinyl-1,4-benzoquinone (DZQ)-DNA adduct by bacterial and mammalian 3-methyladenine-DNA glycosylases. Mol. Cell, 2000, 10, 723-727.
6. Beall, H.D.; Murphy, A.M.; Siegel, D.; Hargreaves, R.H.; Butler, J.; Ross, D. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. Mol. Pharmacol., 1995, 48, 499-504.
7. Winski, S.L.; Hargreaves, R.H.; Butler, J.; Ross, D. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Clin. Cancer Res., 1998, 4, 3083-3088.
8. Sagnou, M.; Strongilos, A.; Hadjipavlou-Litina, D.; Couladouros, E. A. Synthesis of Novel Benzoquinones with Anti-Inflammatory Activity. Lett. Drug Des. Discov., 2009, 6, 172-177.
9. Yezerski, A.; Ciccone, C.; Rozitski, J.; Volingavage, B. The effects of a naturally produced benzoquinone on microbes common to flour. J. Chem. Ecol., 2007, 33, 1217-1225.
10. Awino, O.S.; Kiprono, P.C.; Keronei, K.P.; Kaberia, F.; Obala, A.A. Antimicrobial activity of 2,5-dihydroxy-3-methyl-1,4-benzoquinone from Embelia schimperi. Z Naturforsch. C., 2008, 63, 47-50.
11. Bogdanova, N.S.; Pershin, G.N.; Nikolaeva, I.S.; Grinev, A.N.; Shvedov, V.I. Antiviral activity of p-benzoquinone and hydroquinone derivatives. Farmakol. Toksikol., 1970, 33, 488-496.
12. Aggarwal, B.B.; Kunnumakkara, A.B.; Harikumar, K.B.; Tharakan, S.T.; Sung, B.; Anand, P. Potential of Spice-Derived Phytochemicals for Cancer Prevention. Planta Med., 2008, 74, 1560-1569.
13. Padhye, S.; Banerjee, S.; Ahmad, A.; Mohammad, R.; Sarkar, F.H. From here to eternity -the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. Cancer Ther., 2008, 6, 495-510.
14. Packter, N. M. Studies on the biosynthesis of quinones in fungi. Incorporation of 6-methylsalicylic acid into fumigatin and related compounds in Aspergillus fumigatus I.M.I. 89353, Biochem J., 1965, 97, 321-332.
15. Thomson, R.H. Naturally Occurring Quinones, 2nd ed. Academic Press: London, 1971.
16. Mikami, Y.; Takahashi, K.; Yazawa, K.; Arai, T.; Namikoshi, M.; Iwasaki, S.; Okuda, S. Biosynthetic studies on Safaramycin A:Quinone antitumor antibiotic produced by Streptomyces lavendulae J. Biol.Chem., 1985, 260, 344-348.
17. Morton, R.A. Biochemistry of Quinones, Academic Press: New York, 1965.
18. Patel, I.C.; Skauen, D.M. Ultrasonic extraction of Cassia acutifolia. J.Pharm.Sci., 1969, 58,1135-1139.
19. Scholz, F.; Düsse, H.; Meyer, B. A new pH-sensor based on quinhydrone. Fresenius’ J. Anal. Chem., 1993, 347, 458-459.
20. Hashimoto, M.; Takagia, H.; Yamamuraa, K. Three dimensional supramolecules of triptycene-quinone and its 6, 7-dimethyl derivative formed by weak intermolecular π-π interactions and C-H•••O hydrogen bonds. Tetrahedron. Lett., 1999, 40, 6037-6040.
21. Berkovitch-Yellin, Z.; Leiserowitz, L. The role played by C-H•••O and C-H•••N interactions in determining molecular packing and conformation. Acta Crystallogr., 1984, B40, 159-165.
22. Laskowski, D. E. Influence of structural features on formation of solid charge-transfer complexes of quinones with carcinogenic and related non-carcinogenic electron donors. Cancer Res., 1967, 27, 903-911.
23. Inaba, K.; Takahashi, Y-H.; Ito. K.; Hayashi, S. Critical role of a thiolate-quinone charge transfer complex and its adduct form in de novo disulfide bond generation by DsbB. Proc. Natl. Acad. Sci. USA, 2006, 103, 287-292.
24. Bangal, P. R. Hydrogen-bonding and protonation effects on the formation of charge transfer complex between para-benzoquinone and 2,6-dimethoxy phenol. Chem. Phys. Lett., 2005, 401, 200-204.
25. Regeimbal, J,; Gleiter, S.; Trumpower, B. L.; Yu, C-A.; Diwakar, M.; Ballou, D. P.;Bardwell, J. C.A. Disulfide bond formation involves a quinhydrone-type charge-transfer complex. Proc. Natl. Acad. Sci. USA, 2003, 100, 13779-13784.
26. Fedyanin, I. V.; Lyssenko, K. A.; Vorontsov,a, N. V.; Rozenberg, V.I.; Antipin, M. Y. Transannular interaction in 4,7-[2.2] paracyclophane quinone. Mendleev Commun., 2003, 13, 15-16.
27. Sugiyama, H.; Kamogawa, H. Studies on polymers containing functional groups. III. Chargetransfer interaction between quinone and aza polymers. J. Polym. Sci. Part A-1: Polym. Chem., 2003, 4, 2281-2288
28. Uliana, M. P., Vieira, Y. W.; Donatoni, M.C.; Corrêa, A. G.; Brocksom, U.; Brocksom, T.J. Oxidation of Mono-Phenols to para-Benzoquinones: a Comparative Study. J. Braz. Chem. Soc., 2008, 19, 1484-1489.
29. Thiele, J. Thiele Reaction: Formation of triacetoxy aromatic compounds. Ber., 1898, 31, 1247-1249.
30. Hikosaka, A. The reaction of aliphatic amines with pbenzoquinone, The effect of the alkyl group of amines on the reaction. Bull. Chem. Soc. Jpn., 1970, 43, 3928-3929.
31. Harley-Mason and Laird, A.H. Isolation and structure of the fluorescent substances formed in the oxidative reaction of adrenaline and noradrenaline with ethylenediamine. Tetrahedron, 1959, 7, 70-76.
32. Asahara, T.; Seno, M.; Teshirogi, T. Reaction of p-benzoquinone derivatives with ethylenediamine. Bull. Chem. Soc. Jpn., 1971, 44, 1687-1689.
33. Saeed, A. E. M., and Omer, N. M. A. Synthesis of some 2,5-diamino-3,6-dibromo -1,4-Benzoquinones. Afr. J. Pure. Appl. Chem., 2009, 3, 275-280.
34. Cameron, D.W.; Feutrill, G.I.; Keep, P.L.C. Dichloro quinones as dienophiles: synthesis of alizarin derivatives. Tetrahedron Lett., 1989, 30, 5173-5176.
35. Brown, J.R.; Imam, S.H. Recent studies on doxorubicines and its analougues. In: Progress in Medicinal Chemistry, Ellis, G.P.; West, G.B., Eds. Elsevier Science Publisher B.V.: Amsterdam, 1984; Vol. 21, pp. 169-236.
36. Kende, A.S.; Bentley, T.J.; Mader, R.A.; Ridge, D. Simple total synthesis of (+)-dendrobine. J. Am. Chem. Soc., 1974, 96, 4332-4334.
37. Lora-Tamayo, M. Some results obtained in the utilisation of quinones as philodiene. Tetrahedron, 1958, 4, 17-25.
38. Inouye, Y.; Kakisawa, H. Diels-Alder reaction of benzoquinone. 1. Reactions of methoxy-benzoquinone with styrene and omethoxystyrene. Bull. Chem. Soc. Jpn., 1971, 44, 563-564.
39. Vieira, Y. W.; Brocksom T. J. In: Vitamin K3 synthesis by a multicomponent Diels-Alder reaction, using microwave irradiation, 13th Brazilian meeting on organic synthesis, São Carlos, SP-Brazil, 2009, pp. 565-905.
40. Buckle, R. N.; Liu, P.; Roberts, E. W.D; Burnell, D. J. Differences in rates of diels-alder reactions as experimental indicators of synchronous or asynchronous transition states. Tetrahedron, 1999, 55, 11455-11464.
41. Sollner, S.; Deller, S.; Macheroux, P.; Palfey BA. Mechanism of flavin reduction and oxidation in the redox-sensing quinone reductase Lot6p from Saccharomyces cerevisiae. Biochemistry, 2009, 48, 8636-8643.
42. Sollner, S., Schober, M., Wagner, A., Prem, A., Lorkova, L., Palfey, B.A., Groll, M., Macheroux, P. Quinone reductase acts as a redox switch of the 20S yeast proteasome. EMBO Rep., 2008, 10, 65-70.
43. Malpica, R.; Franco, B.; Rodriguez, C.; Kwon, O.; Georgellis, D. Identification of a quinonesensitive redox switch in the ArcB sensor kinase. Proc. Natl. Acad. Sci. USA, 2004, 101, 13318-13323.
44. Moore, H.W. Bioactivation as a model for drug design. Bioreductive alkylation. Science, 1977, 197, 527-532.
45. Kleyer, D.L.; Koch, T.H. Mechanistic investigation of reduction of daunomycin and 7-deoxydaunomycinone with bi-(3, 5, 5-trimethyl-2-oxomorpholin-3-yl). J. Am. Chem. Soc., 1984, 106, 2380-2387.
46. Bachur, N.R.; Gee, M.V.; Friedman, R.D. Nuclear catalyzed antibiotic free radical formation. Cancer Res., 1982, 42, 1078-1081.
47. Bachur, N.R.; Gordon, S.L.; Gee, M.V. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res., 1978, 38, 1745-1750.
48. Dallner, G.; Stocker, R. Coenzyme Q. In: Encyclopedia of dietary supplements, Marcel Dekker: New York, 2005, pp.121-131
49. Groneberg, D.A.; Kindermann, B.; Althammer, M.; Klapper, M.; Vormann, J.; Littarru, G.P.; Döring, F. Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int. J. Biochem. Cell Biol., 2005, 37, 1208-1218.
50. Sales Santos, I.M.; de Freitas, R.L.; da Silva, E.P.; Feitosa, C.M.; Saldanha, G.B.; Souza, G.F.; da RochaTomé, A.; Feng, D.; de Freitas, R.M. Effects of ubiquinone on hydroperoxide concentration and antioxidant enzymatic activities in the rat hippocampus during pilocarpine-induced seizures. Brain Res., 2010, 1315, 33-40.
51. Littarru, G.P.; Tiano, L. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol. Biotechnol., 2007, 37, 31-37.
52. Stocker, R.; Bowry, V.W.; Frei, B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does a-tocopherol. Proc. Natl. Acad. Sci. USA, 1991, 88, 1646-1650.
53. Witting, P.K.; Pettersson, K.; Letters, J.; Stocker, R. Antiatherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice. Free Radic. Biol. Med., 2000, 29, 295-305.
54. Digiesi, V.; Cantini, F.; Oradei, A.; Bisi, G.; Guarino, G.C.; Brocchi, A.; Bellandi, F.; Mancini, M.; Littarru, G.P. Coenzyme Q10 in essential hypertension. Mol. Aspects Med., 1994, 15, 257-263.
55. Belardinelli, R.; Muçaj, A.; Lacalaprice, F.; Solenghi, M.; Seddaiu, G.; Principi, F.; Tiano, L.; Littarru, G.P. Coenzyme Q10 and exercise training in chronic heart failure. Eur. Heart J., 2006, 27, 2675-2681.
56. Kwong, L.K.; Kamzalov, S.; Rebrin, I.; Bayne, A.C.; Jana, C.K.; Morris, P.; Forster, M.J.; Sohal, R.S. Effects of coenzyme Q (10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic. Biol. Med., 2002, 33, 627-638.
57. Sohal, R.S.; Kamzalov, S.; Sumien, N.; Ferguson, M.; Rebrin, I.; Heinrich, K.R.; Forster, M.J. Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice. Free Radic. Biol. Med., 2006, 40, 480-487.
58. Tiano, T., Belardinelli, R., Carnevali, P., Principi, F., Seddau, G., Littarru, G. P. Effect of Coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischemic heart disease: a double blind randomized controlled study. Eur. Heart J., 2007, 28, 2249-2255.
59. Mancuso, M.; Orsucci, D.; Volpi, L.; Calsolaro, V.; Siciliano, G. Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Curr. Drug Targets, 2010, 11, 111-121.
60. Ratnam, D.V.; Chandraiah, G.; Meena, A.K.; Ramarao, P.; Kumar, M.N. The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorates hyperlipidemia in high fat diet fed rats. J. Nanosci. Nanotechnol., 2009, 9, 6741-6746.
61. Sohet, F.M.; Neyrinck, A.M.; Pachikian, B.D.; de Backer, F.C.; Bindels, L.B.; Niklowitz, P.; Menke, T.; Cani, P.D.; Delzenne, N.M. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem. Pharmacol., 2009, 78, 1391-1400.
62. Kumar, A.; Kaur, H.; Devi, P.; Mohan, V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacol. Ther., 2009, 124, 259-268.
63. Stawiarska-Pieta, B.; Paszczela, A.; Grucka-Mamczar, E.; Szaflarska-Stojko, E.; Birkner, E. The effect of antioxidative vitamins A and E and coenzyme Q on the morphological picture of the lungs and pancreata of rats intoxicated with sodium fluoride. Food Chem. Toxicol., 2009, 47, 2544-2550.
64. Okello, E.; Jiang, X.; Mohamed, S.; Zhao, Q.; Wang, T. Combined statin/coenzyme Q10 as adjunctive treatment of chronic heart failure. Med. Hypotheses, 2009, 73, 306-308.
65. Yang, L.; Calingasan, N.Y.; Wille, E.J.; Cormier, K.; Smith, K.; Ferrante, R.J.; Beal, M.F. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s diseases. J. Neurochem., 2009, 109, 1427-1439.
66. Cordero, M.D.; Moreno-Fernández, A.M.; Gomez-Skarmeta, J.L.; de Miguel, M.; Garrido-Maraver, J.; Oropesa-Avila, M.; Rodríguez-Hernández, A.; Navas, P.; Sánchez-Alcázar, J.A. Coenzyme Q10 and alpha-tocopherol protect against amitriptyline toxicity. Toxicol. Appl. Pharmacol., 2009, 235, 329-337.
67. Sena, C.M.; Nunes, E.; Gomes, A.; Santos, M.S.; Proença, T.; Martins, M.I.; Seiça, R. Supplementation of coenzyme Q10 and alpha-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats. Nutr. Res., 2008, 28, 113-121.
68. Ayaz, M.; Tuncer, S.; Okudan, N.; Gokbel, H. Coenzyme Q (10) and alpha-lipoic acid supplementation in diabetic rats: conduction velocity distributions. Methods Find Exp. Clin. Pharmacol., 2008, 30, 367-374.
69. Nakajima, Y.; Inokuchi, Y.; Nishi, M.; Shimazawa, M.; Otsubo, K.; Hara, H. Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Res., 2008, 1226, 226-233.
70. Kim, D.W.; Hwang, I.K.; Kim, D.W.; Yoo, K.Y.; Won, C.K.; Moon, W.K.; Won, M.H. Coenzyme Q{10} effects on manganese superoxide dismutase and glutathione peroxidase in the hairless mouse skin induced by ultraviolet B irradiation. Biofactors, 2007, 30, 139-147.
71. Ochoa, J.J.; Quiles, J.L.; López-Frías, M.; Huertas, J.R.; Mataix, J. Effect of lifelong coenzyme Q10 supplementation on age-related oxidative stress and mitochondrial function in liver and skeletal muscle of rats fed on a polyunsaturated fatty acid (PUFA)-rich diet. J. Gerontol. A. Biol. Sci. Med. Sci., 2007, 62, 1211-1218.
72. Yuvaraj, S.; Premkumar, V.G.; Vijayasarathy, K.; Gangadaran, S.G.; Sachdanandam, P. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins. Clin. Biochem., 2007, 40, 623-628.
73. Upaganlawar, A.; Farswan, M.; Rathod, S.; Balaraman, R. Modification of biochemical parameters of gentamicin nephrotoxicity by coenzyme Q10 and green tea in rats. Indian J. Exp. Biol., 2006, 44, 416-418.
74. Armstrong, J.S.; Whiteman, M.; Rose, P.; Jones, D.P. The Coenzyme Q10 analog decylubiquinone inhibits the redox-activated mitochondrial permeability. J. Biol. Chem., 2003, 278, 49079-49084.
75. Sala, G.; Trombin, F.; Beretta, S.; Tremolizzo, L.; Presutto, P.; Montopoli, M.; Fantin, M.; Martinuzzi, A.; Carelli, V.; Ferrarese, C. Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids. J. Neurosci. Res., 2008, 86, 3331-3337.
76. Bergamasco, B.; Scarzella, L.; La Commare, P. Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type. Funct. Neurol., 1994, 9, 161-168.
77. Gillis, J.C.; Benefield, P.; McTavish, D. Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders. Drugs Aging, 1994, 5, 133-152.
78. Suno, M.; Nagaoka, A. Inhibition of lipid peroxidation by a novel compound, idebenone (CV-2619). Jpn. J. Pharmacol., 1984, 35,196-198
79. Hirai, K.; Hayako, H.; Kato, K.; Miyamoto, M. Idebenone protects hippocampal neurons against amyloid beta-peptide-induced neurotoxicity in rat primary cultures. Naunyn Schmiedebergs Arch. Pharmacol., 1998, 358, 582-585.
80. Voronkova, K.V.; Meleshkov, M.N. Use of Noben (idebenone) in the treatment of dementia and memory impairments without dementia. Neurosci. Behav. Physiol., 2009, 39, 501-506.
81. Muscoli, C.; Fresta, M.; Cardile, V.; Palumbo, M.; Renis, M.; Puglisi, G.; Paolino, D.; Nisticò, S.; Rotiroti, D.; Mollace, V. Ethanol-induced injury in rat primary cortical astrocytes involves oxidative stress: effect of Idebenone. Neurosci. Lett., 2002, 329, 21-24.
82. Palumbo, M.; Russo, A.; Cardile, V.; Renis, M.; Paolino, D.; Puglisi, G.; Fresta, M. Improved antioxidant effect of Idebenone-loaded polyethyl-2-cyanoacrylate nanocapsules tested on human fibroblasts. Pharm. Res., 2002, 19, 71-78.
83. Grieb, P.; Ryba, M.S.; Debicki, G.S.; Gordon-Krajcer, W.; Januszewski, S.; Chrapusta, S.J. Changes in oxidative stress in the rat brain during post-cardiac arrest reperfusion, and the effect of treatment with the free radical scavenger Idebenone. Resuscitation, 1998, 39, 107-113.
84. Mordente, A.; Martorana, G.E.; Minotti, G.; Giardina, B. Antioxidant properties of 2, 3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1, 4-benzoquinone (idebenone). Chem. Res. Toxicol., 1998, 11, 54-63.
85. Fink, B.D.; O’Malley, Y.; Dake, B.L.; Ross, N.C.; Prisinzano, T.E.; Sivitz, W.I. Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells. PLoS One, 2009, 4, e4250.
86. Tauskela, J.S. MitoQ-a mitochondria-targeted antioxidant. IDrugs, 2007, 10, 399-412.
87. Subramanian, S.; Kalyanaraman, B.; Migrino, R.Q. Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases. Recent Pat. Cardiovasc. Drug Discov., 2009, 5, 54-65.
88. Milagros, R.M.; Victor, V.M. Targeting antioxidants to mitochondria and cardiovascular diseases: the effects of mitoquinone. Med. Sci. Monit., 2007, 13, RA132-145.
89. Kruk, J., Jemiola-Rzeminska, M., Strzalka, K. Plastoquinol and α-tocopherol quinol are more active than ubiquinol and α-tocopherol in inhibition of lipid peroxidation. Chem. Phys. Lipids, 1997, 87, 73-80.
90. Loshadkin, D., Roginsky, V., and Pliss, E. Substituted phydroquinones as a chain-breaking antioxidant during the oxidation of styrene. Int. J. Chem. Kinet., 2002, 34, 162-171.
91. Roginsky, V., Barsukova, T., Loshadkin, D., and Pliss, E. Substituted p-hydroquinones as inhibitors of lipid peroxidation. Chem. Phys. Lipids, 2003, 125, 49-58.
92. Antonenko, Y.N.; Avetisyan, A.V.; Bakeeva, L.E.; Chernyak, B.V.; Chertkov, V.A.; Domnina, L.V.; Ivanova, O.Y.; Izyumov, D.S.; Khailova, L.S.; Klishin, S.S.; Korshunova, G.A.; Lyamzaev, K.G.; Muntyan, M.S.; Nepryakhina, O.K.; Pashkovskaya, A.A.; Pletjushkina, O.Y.; Pustovidko, A.V.; Roginsky, V.A.; Rokitskaya, T.I.; Ruuge, E.K.; Saprunova, V.B.; Severina, I.I.; Simonyan, R.A.; Skulachev, I.V.; Skulachev, M.V.; Sumbatyan, N.V.; Sviryaeva, I.V.; Tashlitsky, V.N.; Vassiliev, J.M.; Vyssokikh, M.Y.; Yaguzhinsky, L.S.; Zamyatnin, A.A. Jr; Skulachev, V.P. Mitochondriatargeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry (Mosc)., 2008, 73, 1273-1287.
93. Antonenko, Y.N.; Roginsky, V.A.; Pashkovskaya, A.A.; Rokitskaya, T.I.; Kotova, E.A.; Zaspa, A.A.; Chernyak, B.V.; Skulachev, V.P. Protective effects of mitochondria-targeted antioxidant SkQ in aqueous and lipid membrane environments. J. Membr. Biol., 2008, 222, 141-149
94. Bakeeva, L.E.; Barskov, I.V.; Egorov, M.V.; Isaev, N.K.; Kapelko, V.I.; Kazachenko, A.V.; Kirpatovsky, V.I.; Kozlovsky, S.V.; Lakomkin, V.L.; Levina, S.B.; Pisarenko, O.I.; Plotnikov, E.Y.; Saprunova, V.B.; Serebryakova, L.I.; Skulachev, M.V.; Stelmashook, E.V.; Studneva, I.M.; Tskitishvili, O.V.; Vasilyeva, A.K.; Victorov, I.V.; Zorov, D.B.; Skulachev, V.P. Mitochondriatargeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS-and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochemistry (Mosc), 2008, 73, 1288-1299.
95. Iwashima, M.; Mori, J.; Ting, X.; Matsunaga, T.; Hayashi, K.; Shinoda, D.; Saito, H.; Sankawa, U.; Hayashi, T. Antioxidant and antiviral activities of plastoquinones from the brown alga Sargassum micracanthum, and a new chromene derivative converted from the plastoquinones. Biol. Pharm. Bull., 2005, 28, 374-377.
96. Tageja, N.; Padhye, S.; Dandawate, P.; Al-Katib, A; Mohammad, R.M. New targets for the treatment of follicular lymphoma. J. Hematol. Oncol., 2009, 23, 2:50
97. Al-Ali, A.; Alkhawajah, A.A.; Randhawa, M.A.; Shaikh, N.A. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J. Ayub. Med. Coll. Abbottabad, 2008, 20, 2025-2027.
98. Ragheb, A.; Attia, A.; Elbarbry, F.; Prasad, K.; Shoker, A. Attenuated combined action of cyclosporine a and hyperlipidemia on atherogenesis in rabbits by thymoquinone. Evid Based Complement Alternat. Med., 2009, [Epub ahead of print]
99. Ismail, M.; Al-Naqeep, G.; Chan, K.W. Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radic. Biol. Med., 2009, 48, 664-672.
100. Hamdy, N.M.; Taha, R.A. Effects of Nigella sativa oil and thymoquinone on oxidative stress and neuropathy in streptozotocininduced diabetic rats. Pharmacology, 2009, 84, 127-134.
101. Chandra, S.; Mondal, D.; Agrawal, K.C. HIV-1 protease inhibitor induced oxidative stress suppresses glucose stimulated insulin release:protection with thymoquinone. Exp. Biol. Med. (Maywood)., 2009, 234, 442-453.
102. Fouda, A.M.; Daba, M.H.; Dahab, G.M.; Sharaf El-Din, O.A. Thymoquinone ameliorates renal oxidative damage and proliferative response induced by mercuric chloride in rats. Basic Clin. Pharmacol. Toxicol., 2008, 103, 109-118.
103. Kruk, I.; Michalska, T.; Lichszteld, K.; Kladna, A.; boul-Enein. H.Y. The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere, 2000, 41, 1059-1064.
104. Mansour, M.A.; Nagi, M.N.; El-Khatib, A.S.; Al-Bekairi, A.M.. Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action. Cell. Biochem. Funct., 2002, 20, 143-151.
105. Al-Enazi, M.M. Effect of thymoquinone on malformations and oxidative stress-induced diabetic mice. Pak. J. Biol. Sci., 2007, 10, 3115-9.
106. Badary, O.A.; al-Shabanah, O.A.; Nagi, M.N.; al-Rikabi, A.C.; Elmazar, M.M. Inhibition of benzo(a)pyreneinduced forestomach carcinogenesis in mice by thymoquinone. Eur. J. Cancer Prev., 1999, 8, 435-440.
107. Badary, O.A.; Abd-Ellah, M.F.; El-Mahdy, M.A.; Salama, S.A.; Hamada, F.M. Anticlastogenic activity of thymoquinone against benzo(a)pyrene in mice. Food Chem. Toxicol., 2007, 45, 88-92.
108. Badary, O.A.; Abdel-Naim, A.B.; Abdel-Wahab, M.H.; Hamada, F.M. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicology, 2000, 143, 219-226.
109. Sayed-Ahmed, M.M.; Nagi, M.N. Thymoquinone supplementation prevents the development of Gentamicin induced acute renal toxicity in rats. Clin. Exp. Pharmacol. Physiol., 2007, 34, 399-405.
110. El-Saleh, S.C.; Al-Sagair, O.A.; Al-Khalaf, M.I. Thymoquinone and Nigella sativa oil protection against methionine-induced hyperhomocysteinemia in rats. Int. J. Cardiol., 2004, 93, 19-23.
111. Mahgoub, A.A. Thymoquinone protects against experimental colitis in rats. Toxicol. Lett., 2003, 143, 133-143.
112. Al-Shabanah, O.A.; Badary, O.A.; Nagi, M.N.; Al-Gharably, N.M.; Al-Rikabi, A.C.; Al-Bekairi, A.M. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. J. Exp. Clin. Cancer Res., 1998, 17, 193-198.
113. Al-Majed, A.A.; Al-Omar, F.A.; Nagi, M.N. Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus. Eur. J. Pharmacol., 2006, 543, 40-47.
114. Singh, D.; Singh, R.; Singh, P.; Gupta, R.S. Effects of Embelin on Lipid Peroxidation and Free Radical Scavenging Activity against Liver Damage in Rats. Basic Clin. Pharmacol. Toxicol., 2009 [Epub ahead of print].
115. Bhandari, U.; Kanojia, R.; Pillai, K.K. Effect of ethanolic extract of Embelia ribes on dyslipidemia in diabetic rats. Int. J. Exp. Diabetes Res., 2002, 3, 159-162.
116. Bhandari, U.; Jain, N.; Pillai, K.K. Further studies on antioxidant potential and protection of pancreatic beta-cells by Embelia ribes in experimental diabetes. Exp. Diabetes Res., 2007, 15, 1-6.
117. Fieser, L.F.; Chamberlin, E.M. Synthesis of embelin, rapoanne and related quinones by peroxide alkylation. J. Am. Chem. Soc., 1948, 70, 71-75.
118. Rasheed, K.K.A.; Chacko, J.; Nambisan, P.N.K. Thermal, spectral and magnetic studies on some transition metal complexes of Embelin. Polyhedron., 1983, 2, 293-299.
119. Abraham, R.; Yussuf, K.K.M. Copper (II) complexes of embelin and 2-aminobenzimidazole encapsulated in zeolite Y-potential as catalysts for reduction of dioxygen. J. Mol. Catal. A: Chem., 2003, 198, 175-183.
120. Joshi, R.; Kamat, J.P.; Mukherjee, T. Free radical scavenging reactions and antioxidant activity of embelin: biochemical and pulse radiolytic studies. Chem. Biol. Interact., 2007, 167, 125-134.
121. Shatalin, I.V.; Naumov, A.A.; Potselueva, M.M. A comparison of antioxidant properties of hypoxen and duroquinone by the method of chemiluminescence. Biofizika, 2008, 53, 100-106.
122. Terao, S.; Ohkawa, S.; Terashita, Z.; Shibouta, Y.; Nishikawa, K. Synthesis and biological evaluation of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone (CV-6504), a dual inhibitor of TXA2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species (AOS). Adv Prostaglandin Thromboxane. Leukot. Res., 1991, 21A, 173-176.
123. Lee, I.K.; Yun, B.S.; Cho, S.M.; Kim, W.G.; Kim, J.P.; Ryoo, I.J.; Koshino, H.; Yoo, I.D. Betulinans A and B, two benzoquinone compounds from Lenzites betulina. J. Nat. Prod., 1996, 59, 1090-1092.
124. Mori, K.; Ushio, T.; Okamoto, T.; Kishi, T.; Sayo, H. Effect of arylthiolated 2, 3-dimethoxy-1,4-benzoquinones on respiratory activity and lipid peroxidation in bovine heart mitochondria. Biol. Pharm. Bull., 1998, 21, 293-296.
125. Choi, B.S.; Song, H.S.; Kim, H.R.; Park, T.W.; Kim, T.D.; Cho, B.J.; Kim, C.J.; Sim, S.S. Effect of coenzyme Q10 on cutaneous healing in skin-incised mice. Arch. Pharm. Res., 2009, 32, 907-913.
126. Novoselova, E.G.; Lunin, S.M.; Novoselova, T.V.; Khrenov, M.O.; Glushkova, O.V.; Avkhacheva, N.V.; Safronova, V.G.; Fesenko, E.E. Naturally occurring antioxidant nutrients reduce inflammatory response in mice. Eur. J. Pharmacol., 2009, 615, 234-240.
127. Schmelzer, C.; Kitano, M.; Rimbach, G.; Niklowitz, P.; Menke, T.; Hosoe, K.; Döring, F. Effects of ubiquinol-10 on microRNA-146a expression in vitro and in vivo. Mediators Inflamm., 2009, 2009, 415437.
128. Lee, T.I.; Kao, Y.H.; Chen, Y.C.; Chen, Y.J. Proinflammatory cytokine and ligands modulate cardiac peroxisome proliferatoractivated receptors. Eur. J. Clin. Invest., 2009, 39, 23-30.
129. Chew, G.T.; Watts, G.F. Coenzyme Q10 and diabetic endotheliopathy:oxidative stress and the ‘recoupling hypothesis. Q J. Med., 2004, 97, 537-548.
130. Lowes, D.A.; Thottakam, B.M.; Webster, N.R.; Murphy, M.P.; Galley, H.F. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic. Biol. Med., 2008, 45, 1559-1565.
131. Civenni, G.; Bezzi, P.; Trotti, D.; Volterra, A.; Racagni, G. Inhibitory effect of the neuroprotective agent idebenone on arachidonic acid metabolism in astrocytes. Eur. J. Pharmacol., 1999, 370, 161-167.
132. Mansour, M.; Tornhamre, S. Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. J. Enzyme Inhibit. Med. Chem., 2004, 19, 431-436.
133. El-Mahmoudy, A.; Matsuyama, H.; Borgan, M.A.; Shimizu, Y.; El-Sayed, M.G.; Minamoto, N.; Takewaki, T. Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. Int. Immunopharmacol., 2002, 2, 1603-1611.
134. Juhás, S.; Cikos, S.; Czikková, S.; Veselá, J.; Il’ková, G.; Hájek, T.; Domaracká, K.; Domaracký, M.; Bujnáková, D.; Rehák, P.; Koppel, J. Effects of borneol and thymoquinone on TNBS-induced colitis in mice. Folia Biol. (Praha)., 2008, 54, 1-7.
135. El Gazzar, M.A. Thymoquinone suppressses in vitro production of IL-5 and IL-13 by mast cells in response to lipopolysaccharide stimulation. Inflamm. Res., 2007, 56, 345-351.
136. Hajhashemi, V.; Ghannadi, A.; Jafarabadi, H. Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother. Res., 2004, 18, 195-199.
137. El Gazzar, M.A.; El Mezayen, R.; Marecki, J.C.; Nicolls, M.R.; Canastar, A.; Dreskin, S.C. Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int. Immunopharmacol., 2006, 6, 1135-1142.
138. Sayed, A.A.; Morcos, M. Thymoquinone decreases AGE-induced NF-kappaB activation in proximal tubular epithelial cells. Phytother. Res., 2007, 21, 898-899.
139. Ragheb, A.; Attia, A.; Eldin, W.S.; Elbarbry, F.; Gazarin, S.; Shoker, A. The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: a review. Saudi J. Kidney Dis. Transpl., 2009, 20, 741-752.
140. Kanter, M. Protective effects of thymoquinone on streptozotocininduced diabetic nephropathy. J. Mol. Histol., 2009, 40, 107-115.
141. Chitra, M.; Sukumar, E.; Suja, V.; Devi, C.S. Antitumor, antiinflammatory and analgesic property of embelin, a plant product. Chemotherapy, 1994, 40, 109-113.
142. Ahn, K.S.; Sethi, G.; Aggarwal, B.B. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Mol. Pharmacol., 2007, 71, 209-219.
143. Gupta, O.P.; Ali, M.M.; Ray Ghatak, B.J.; Atal, C.K. Some pharmacological investigations of embelin and its semisynthetic derivatives. Indian J. Physiol. Pharmacol., 1977, 21, 31-39.
144. Poulaki, V.; Iliaki, E.; Mitsiades, N.; Mitsiades, C.S.; Paulus, Y.N.; Bula, D.V.; Gragoudas, E.S.; Miller, J.W. Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis. FASEB J., 2007, 21, 2113-2123.
145. Murphy, P.; Sharp, A.; Shin, J.; Gavrilyuk, V.; Dello Russo, C.; Weinberg, G.; Sharp, F.R.; Lu, A.; Heneka, M.T.; Feinstein, D.L. Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis. J. Neurosci. Res., 2002, 67, 461-470.
146. Malhotra, V.; Shanley, T.P.; Pittet, J.F.; Welch, W.J.; Wong, H.R. Geldanamycin inhibits NF-kappaB activation and interleukin-8 gene expression in cultured human respiratory epithelium. Am. J. Respir. Cell Mol. Biol., 2001, 25, 92-97.
147. Bucci, M.; Roviezzo, F.; Cicala, C.; Sessa, W.C.; Cirino, G. Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. Br. J. Pharmacol., 2000, 131, 13-16.
148. Alhosin, M.; Abusnina, A.; Achour, M.; Sharif, T.; Muller, C.; Peluso, J.; Chataigneau, T.; Lugnier, C.; Schini-Kerth, V.B.; Bronner, C.; Fuhrmann, G. Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1. Biochem. Pharmacol., 2010, 79, 1251-1260.
149. El-Najjar, N.; Chatila, M.; Moukadem, H.; Vuorela, H.; Ocker, M.; Gandesiri, M.; Schneider-Stock, R.; Gali-Muhtasib, H. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis, 2010, 15, 183-195
150. Banerjee, S.; Kaseb, A.O.; Wang, Z.; Kong, D.; Mohammad, M.; Padhye, S.; Sarkar, F.H.; Mohammad, R.M. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Res., 2009, 69, 5575-5583
151. Breyer, S.; Effenberger, K.; Schobert, R. Effects of thymoquinonefatty acid conjugates on cancer cells. ChemMedChem., 2009, 4, 761-768.
152. Yamasaki, L. Role of the RB tumor suppressor in cancer. Cancer Treat Res., 2003, 115, 209-239
153. El-Mahdy, M.A.; Zhu, Q.; Wang, Q.E.; Wani, G.; Wani, A.A. Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int. J. Cancer, 2005, 117, 409-417.
154. Kaseb, A.O.; Chinnakannu, K.; Chen, D.; Sivanandam, A.; Tejwani, S.; Menon, M.; Dou, Q.P.; Reddy, G.P. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Cancer Res., 2007, 67, 7782-7788.
155. Sethi, G.; Ahn, K.S.; Aggarwal, B.B. Targeting nuclear factor-{kappa}B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol. Cancer Res., 2008, 6, 1059-1070.
156. Gali-Muhtasib, H.; Kuester, D.; Mawrin, C.; Bajbouj, K.; Diestel, A.; Ocker, M.; Habold, C.; Foltzer-Jourdainne, C.; Schoenfeld, P.; Peters, B.; ab-Assaf, M.; Pommrich, U.; Itani, W.; Lippert, H.; Roessner, A.; Schneider-Stock, R. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res., 2008, 68, 5609-5618.
157. Gali-Muhtasib, H.; ab-Assaf, M.; Boltze, C.; Al-Hmaira, J.; Hartig, R.; Roessner, A.; Schneider-Stock, R. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int. J. Oncol., 2004, 25, 857-866.
158. Gali-Muhtasib, H.U.; bou Kheir, W.G.; Kheir, L.A.; Darwiche, N.; Crooks, P.A. Molecular pathway for thymoquinone-induced cellcycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs, 2004, 15, 389-399.
159. Roepke, M.; Diestel, A.; Bajbouj, K.; Walluscheck, D.; Schonfeld, P.; Roessner, A., Schneider-Stock, R.; Gali-Muhtasib, H. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol. Ther., 2007, 6, 160-169
160. Reindl, W.; Yuan, J.; Kramer, A.; Strebhardt, K.; Berg, T. Inhibition of polo-like kinase 1 by blocking polobox domain-dependent protein-protein interactions. Chem. Biol., 2008, 15, 459-466.
161. Ivankovic, S.; Stojkovic, R.; Jukic, M.; Milos, M.; Milos, M.; Jurin, M. The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo. Exp. Oncol., 2006, 28, 220-224.
162. Badary, O.A.; bd-Ellah, M.F.; El-Mahdy, M.A.; Salama, S.A.; Hamada, F.M. Anticlastogenic activity of thymoquinone against benzo(a)pyrene in mice. Food Chem. Toxicol., 2007, 45, 88-92.
163. Tan, M.; Norwood, A.; May, M.; Tucci, M.; Benghuzzi, H. Effects of (-) epigallocatechin gallate and thymoquinone on proliferation of PANC-1 cell line in culture. Biomed. Sci. Instr., 2006, 42, 363-371.
164. Bawadi, H.A.; Bansode, R.R.; Losso, J.N. In: Thymoquinone in the control of hypoxia-induced angiogenic disease biomarkers: Insight into the mechanism of action in vitro, IFT Annual Meeting 2004, Las Vegas NV, USA, 2004, pp 7-12.
165. Brewer, J.; Benghuzzi, H.; Tucci, M. Effects of thymoquinone, lycopene, and selenomethione in the presence of estrogen on the viability of SiHa cells in vitro. Biomed. Sci. Instr., 2006, 42, 37-41.
166. Dai, Y.; Qiao, L.; Chan, K.W.; Yang, M.; Ye, J.; Ma, J.; Zou, B.; Gu, Q.; Wang, J.; Pang, R.; Lan, H.Y.; Wong. B. C. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis: Cancer Res., 2009, 69, 4776-4783.
167. Xu, M.; Cui, J.; Fu. H.; Proksch, P.; Lin, W.; Li, M. Embelin derivatives and their anticancer activity through microtubule disassembly. Planta Med., 2005, 71, 944-948.
168. Mori, T.; Doi, R.; Kida, A.; Nagai, K.; Kami, K.; Ito, D.; Toyoda, E.; Kawaguchi, Y.; Uemoto, S. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. J. Surg. Res., 2007, 142, 281-286.
169. Chen, J.; Nikolovska-Coleska, Z.; Wang, G.; Qiu, S.; Wang. S. Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein. Bioorg. Med. Chem. Lett., 2006, 16, 5805-5808.
170. Podolak, I.; Galanty, A.; Janeczko, Z. Cytotoxic activity of embelin from Lysimachia punctata. Fitoterapia, 2005, 76, 333-335.
171. Miyata, Y. Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents. Curr. Pharm. Des., 2005, 11, 1131-1138
172. Cysyk, R.L.; Parker, R.J.; Barchi, J.J.; Jr, Steeg, P.S.; Hartman, N.R.; Strong, J.M. Reaction of geldanamycin and C17-substituted analogues with glutathione: product identifications and pharmacological implications. Chem. Res. Toxicol., 2006, 19, 376-381.
173. Rosenhagen, M.C.; Young, J.C.; Wochnik, G.M.; Herr, A.S.; Schmidt, U.; Hartl, F.U.; Holsboer, F.; Rein, T. Synergistic inhibition of the glucocorticoid receptor by radicicol and benzoquinone ansamycins. Biol. Chem., 2001, 382, 499-504.
174. Kaur, G.; Belotti, D.; Burger, A.M.; Fisher-Nielson, K.; Borsotti, P.; Riccardi, E.; Thillainathan, J.; Hollingshead, M.; Sausville, E.A.; Giavazzi, R. Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator. Clin. Cancer Res., 2004, 15, 4813-4821.
175. Benchekroun, M.N.; Myers, C.E.; Sinha, B.K. Free radical formation by ansamycin benzoquinone in human breast tumor cells: Implications for cytotoxicity and resistance. Free Radic. Biol. Med., 1994, 17, 191-200.
176. Tian, Z.; Liu, Y.; Zhang, D.; Wang, Z.; Dong, S.D.; Carreras, C.W.; Zhou, Y.; Rastelli, G.; Santi, D.V.; Myles, D.C. Synthesis and biological activities of novel 17-aminogeldanamycin derivatives. Bioorg. Med. Chem., 2004, 12, 5317-5329
177. Yun, C.H.; Yoon, S.Y.; Nguyen, T.T.; Cho, H.Y.; Kim. T.H.; Kim, S.T.; Kim, B.C.; Hong, Y. S.; Kim, S.J.; Lee, H.J. Geldanamycin inhibits TGF-beta signaling through induction of Hsp70. Arch. Biochem. Biophys., 2010, 495, 8-13.
178. Lukasiewicz, E.; Miekus, K.; Kijowski, J.; Gozdzik, J.; Wilusz, M.; Bobis-Wozowicz, S.; Wiecha, O.; Majka, M. High anti tumor activity against rhabdomyosarcoma cells and low normal cells cytotoxicity of heat shock protein 90 inhibitors, with special emphasis on 17-[2-(pyrrolidin-1-yl)ethyl]-aminno-17-demethoxygeldanamycin. J. Physiol. Pharmacol., 2009, 60, 161-166.
179. Georgakis, G.V.; Li, Y.; Rassidakis, G.Z.; Martinez-Valdez, H.; Medeiros, L.J.; Younes, A. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin’s lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Clin. Cancer Res., 2006, 12, 584-590
180. Lee, K.; Ryu, J.S.; Jin. Y.; Kim, W.; Kaur, N.; Chung, S.J.; Jeon, Y.J.; Park, J.T.; Bang, J.S.; Lee, H.S.; Kim, T.Y.; Lee, J.J.; Hong, Y.S. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites. Org. Biomol. Chem., 2008, 6, 340-348.
181. Onyüksel, H.; Mohanty, P.S.; Rubinstein, I. VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer. Int. J. Pharm., 2009, 365, 157-161.
182. Cheng, H.; Cao, Z.; Xian, M.; Fang, L.; Cai, T.B.; Ji, J.J.; Tunac, J.B.; Sun, D.; Wang, P.G. Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity. J. Med. Chem., 2005, 48, 645-652.
183. Tian, Z.Q.; Wang, Z.; MacMillan, K.S.; Zhou, Y.; Carreras, C.W.; Mueller, T.; Myles, D.C.; Liu, Y. Potent cytotoxic C-11 modified geldanamycin analogues. J. Med. Chem., 2009, 52, 3265-3273.
184. Fararh, K.M.; Ibrahim, A.K.; Elsonosy, Y.A. Thymoquinone enhances the activities of enzymes related to energy metabolism in peripheral leukocytes of diabetic rats. Res Vet Sci., 2009 [Epub ahead of print].
185. Pari, L.; Sankaranarayanan, C. Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats. Life Sci., 2009, 85, 830-834.
186. Lin, B.; Li, Z.; Park, K.; Deng, L.; Pai, A.; Zhong, L.; Pirrung, M.C.; Webster, M.J.C. Identification of Novel Orally Available Small Molecule Insulin Mimetics. J. Pharmacol. Exp. Ther., 2007, 323, 579-585.
187. Kumara Swamy, H.M.; Krishna, V.; Shankarmurthy, K.; Abdul Rahiman, B.; Mankani, K.L.; Mahadevan, K.M.; Harish, B.G.; Raja Naika, H. Wound healing activity of Embelin isolated from the ethanol extract of leaves of Embelia ribes Burm. J. Ethnopharmacol., 2007, 109, 529-534.